Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ackman’s $CP Pick Harrison Under Fire By $CN, May $CP Proxy Set

Canadian National Railway (CNI) “suspended the pension benefits of former Chief Executive Hunter Harrison and was seeking court approval to cancel them, ratcheting up pressure on the executive to end his pursuit of the top job at ,” reports the Wall Street Journal. Bill Ackman, the activist investor whose hedge fund Pershing Square owns a 14.2% stake in CP, has been pushing to install Harrison as a replacement for CP’s current CEO . CN said Monday that Harrison “breached and intends to breach his contractual undertakings to the company,” because of his interest in the Canadian Pacific position. Harrison’s lawyer, Gregory Joseph, called CN’s lawsuit “frivolous.”


Ackman’s efforts, to date, have been unsuccessful. CP Rail’s board has expressed their unanimous support for Green and filed open, and arguably heated letters to that effect. Now, “Ackman is seeking a proxy vote, which will take place at the company’s annual meeting May 17 in Calgary, to replace Canadian Pacific directors to achieve his goal,” writes the Wall Street Journal. “In a release late Monday, Canadian Pacific said Mr. Ackman’s nominees to the board are himself, Gary Colter, Paul Hilal, Rebecca MacDonald and Anthony Melman.” CP’s board “comprises 15 highly qualified directors, 13 of whom are independent,” said CP Rail Chairman said. Cleghorn also said the company stands by an offer for Ackman to join the board so a “constructive board-level dialogue” can begin.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!